Showing results (211-220 of 247) with videos related to
Sort By:
Pageof 25
Plos One|April 7, 2018
Genetic modulation of atrial fibrillation risk in a Hispanic/Latino cohortBrandon Chalazan, Denise Mol, Arvind Sridhar, et al.Journal of the American College of Cardiology|December 1, 1983
Electrophysiologic actions of high plasma concentrations of propranolol in human subjectsH J Duff, D M Roden, L Brorson, et al.Clinical Pharmacology and Therapeutics|January 21, 2011
The emerging role of electronic medical records in pharmacogenomicsR A Wilke, H Xu, J C Denny, et al.The Journal of Clinical Investigation|March 1, 1990
Suppression of ventricular arrhythmias in man by d-propranolol independent of beta-adrenergic receptor blockadeK T Murray, C Reilly, R P Koshakji, et al.Journal of Cardiovascular Electrophysiology|September 1, 1994
Effects of procainamide and lidocaine on defibrillation energy requirements in patients receiving implantable cardioverter defibrillator devicesD S Echt, S T Gremillion, J T Lee, et al.The Pharmacogenomics Journal|May 16, 2012
Novel rare variants in congenital cardiac arrhythmia genes are frequent in drug-induced torsades de pointesA H Ramirez, C M Shaffer, J T Delaney, et al.Clinical Pharmacology and Therapeutics|January 15, 2014
Green tea ingestion greatly reduces plasma concentrations of nadolol in healthy subjectsS Misaka, J Yatabe, F Müller, et al.Proceedings of the National Academy of Sciences of the United States of America|September 14, 2000
A common polymorphism associated with antibiotic-induced cardiac arrhythmiaF Sesti, G W Abbott, J Wei, et al.JAMA Network Open|January 16, 2019
Association Between Family History and Early-Onset Atrial Fibrillation Across Racial and Ethnic GroupsZain Alzahrani, Aylin Ornelas-Loredo, Sara D Darbar, et al.Clinical Pharmacology and Therapeutics|August 1, 1986
Encainide disposition in patients with chronic cirrhosisR H Bergstrand, T Wang, D M Roden, et al.Pageof 25